Delivery Order SPE2DB22D3011-SPE2DB24FP9NV
- Not listed
- This federal contract award, valued at $3,802.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract is a delivery order that provides the ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical product. This award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $1,353.80, is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award, valued at $29,643.33, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of pharmaceutical products, including the medication ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of December 22, 2023 and is a Firm Fixed Price arrangement. This award is not associated with a set-aside designation, indicating open...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,658.01 delivery order is for ZEPBOUND 15 MG/0.5 ML PEN 0.5ML pharmaceutical products, with a completion date of December 29, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $50,724.28, is a delivery order for the medical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML." The contract has a completion date of February 13, 2024 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,658.32 firm fixed-price delivery order is for the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML." This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a...
- This federal contract award, with ID SPE2DB24D1104|SPE2DB24FXXQ2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a pharmaceutical product, with a ceiling value of $5,941.22 and a period of performance ending on May 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at $1,353.80, is a Firm Fixed Price Delivery Order with a completion date of February 29, 2024. The award includes the supply of a specific medication, ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, but does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The award, valued at $15,164.66, is a Firm Fixed Price delivery order contract with a completion date of January 19, 2024. The contract covers the procurement of a specific medical product, "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML," with no set-aside designation. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $17,699.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for a delivery order of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of March 7, 2024. The contract type is Firm Fixed Price. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP9NVDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $8,151.15, is for the delivery of pharmaceutical products, specifically ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, to support military and veteran healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA, supporting the healthcare needs of the Department of Defense and Department of Veterans Affairs. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 2/29/24 |